Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position

Diana Álvarez1 Dorothy P and Richard P Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical Center, Pittsburgh, PA, USA;2 Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Melanie Levine1 Dorothy P and Richard P Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Mauricio Rojas1 Dorothy P and Richard P Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical Center, Pittsburgh, PA, USA;2 Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA;3 McGowan Institute for Regenerative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USACorrespondence[email protected]

Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date